Clearmind Medicine Inc. Common Shares
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It d… Read more
Clearmind Medicine Inc. Common Shares - Asset Resilience Ratio
Clearmind Medicine Inc. Common Shares (CMND) has an Asset Resilience Ratio of 19.50% as of October 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Clearmind Medicine Inc. Common Shares's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Clearmind Medicine Inc. Common Shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.66 Million | 19.5% |
| Total Liquid Assets | $1.66 Million | 19.50% |
Asset Resilience Insights
- Good Liquidity Position: Clearmind Medicine Inc. Common Shares maintains a healthy 19.50% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Clearmind Medicine Inc. Common Shares Industry Peers by Asset Resilience Ratio
Compare Clearmind Medicine Inc. Common Shares's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Clearmind Medicine Inc. Common Shares (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Clearmind Medicine Inc. Common Shares.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-10-31 | 27.33% | $2.33 Million | $8.53 Million | +23.34pp |
| 2024-10-31 | 3.99% | $402.83K | $10.10 Million | +2.54pp |
| 2023-10-31 | 1.45% | $86.11K | $5.95 Million | -22.00pp |
| 2022-10-31 | 23.44% | $262.98K | $1.12 Million | -- |
| 2021-10-31 | 0.00% | $0.00 | $4.16 Million | -- |